The second of a 5-part webinar series examining value assessment in the COVID-19 era hosted by ISPOR and the Innovation and Value Initiative (IVI) will explore whether the methods on which health economists have relied are up to the task or in need of improvement for the pandemic era.
The second of a 5-part webinar series examining value assessment in the COVID-19 era hosted by ISPOR and the Innovation and Value Initiative (IVI) will explore whether the methods on which health economists have relied are up to the task or in need of improvement for the pandemic era.
Moderated by Lou Garrison, PhD; University of Washington, panelists Charles Phelps, PhD; University of Rochester; Anirban Basu, PhD; University of Washington; Susan Griffin, PhD; University of York; and Dan Ollendorf, PhD; Tufts Medical Center will discuss what changes in value assessment methods may be needed to assess value among rapidly developing interventions, including vaccines, treatments, tests, and non-medical care.
“Our webinar series looks at value assessment through today’s pandemic lens to explore how it can be improved to meet the moment,” says Jennifer Bright, executive director, IVI. “This is an incredibly important and relevant discussion for all healthcare decision makers.”
The webinar will be from 1:00 PM -2:15 PM EST on Thursday, August 27. Register for the webinar by clicking here www.ispor.org/webinars-COVID-IVI.Space is limited, so register today!
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More